http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-WO2009054181-A1
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2430-24 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-734 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-734 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 |
filingDate | 2008-08-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2011-03-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | JP-WO2009054181-A1 |
titleOfInvention | Composition for treating joint diseases |
abstract | The present invention provides a composition for the treatment of joint diseases, characterized by containing, as an active ingredient, a monovalent metal salt of alginic acid whose endotoxin level has been lowered to an extent that does not substantially cause inflammation or fever. This protects cartilage from mechanical stimulation, suppresses cartilage degeneration due to wear and inflammation, repairs cartilage damage, suppresses joint tissue inflammation and pain, synovial tissue degeneration It is possible to provide a composition for treating joint diseases having both an effect of suppressing osteoclasts and an effect of suppressing osteochondral destruction. |
priorityDate | 2007-10-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 98.